Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | KRYS | NUVL | ||
| Company | Cytokinetics | Krystal Biotech Inc | Nuvalent Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 79.41 | 350.00 | 123.40 | ||
| High | 80.15 | 356.50 | 123.56 | ||
| Low | 77.14 | 343.48 | 123.30 | ||
| Latest | 78.78 | 348.06 | 123.43 | ||
| Change | +0.67 | +6.40 | +0.07 | ||
| % Change | +0.86% | +1.87% | +0.06% | ||
| Volume | 3,547,400 | 811,400 | 4,603,500 | ||
| 20-Day Average Volume | 1,926,845 | 296,830 | 4,969,030 | ||
| Previous Close | 78.11 | 341.66 | 123.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 73.37 | 311.78 | 108.51 | ||
| 20-Day Raw Stochastic | 89.87% | 88.18% | 99.48% | ||
| 20-Day Relative Strength | 61.00 | 69.74 | 63.87 | ||
| Weighted Alpha | +85.90 | +160.98 | +39.31 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.73% since 06/11/26 | +8.25% since 06/11/26 | -0.02% since 06/11/26 | ||
| Low | 68.84 on 06/15/26 | 314.00 on 06/15/26 | 123.16 on 06/12/26 | ||
| High | 80.15 on 06/18/26 | 356.50 on 06/18/26 | 123.56 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | +4.79% since 05/18/26 | +19.30% since 05/18/26 | +23.55% since 05/18/26 | ||
| Low | 66.63 on 06/10/26 | 285.07 on 06/02/26 | 87.30 on 06/08/26 | ||
| High | 80.15 on 06/18/26 | 356.50 on 06/18/26 | 123.62 on 06/09/26 | ||
| 3-Month | |||||
| %Chg | +26.68% since 03/18/26 | +38.76% since 03/18/26 | +26.69% since 03/18/26 | ||
| Low | 58.65 on 04/29/26 | 242.00 on 03/31/26 | 87.30 on 06/08/26 | ||
| High | 80.20 on 05/05/26 | 356.50 on 06/18/26 | 123.62 on 06/09/26 | ||
| 6-Month | |||||
| %Chg | +26.66% since 12/18/25 | +49.15% since 12/18/25 | +21.71% since 12/18/25 | ||
| Low | 58.43 on 03/13/26 | 231.90 on 12/19/25 | 87.30 on 06/08/26 | ||
| High | 80.20 on 05/05/26 | 356.50 on 06/18/26 | 123.62 on 06/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,802,831 | 10,260,805 | 9,750,723 | ||
| Shares Outstanding, K | 124,433 | 29,480 | 78,998 | ||
| Annual Sales | 88,040,000 | 389,130,000 | 0 | ||
| Annual Net Income | -784,960,000 | 204,830,000 | -425,380,000 | ||
| Last Quarter Sales | 19,360,000 | 116,360,000 | 0 | ||
| Last Quarter Net Income | -206,030,000 | 55,930,000 | -109,280,000 | ||
| 60-Month Beta | 0.42 | 0.53 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.67 on 05/05/26 | 1.83 on 05/04/26 | -1.39 on 05/07/26 | ||
| Earnings Date | 08/06/26 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 45.68 | 0.00 | ||